In case you missed it: News bites for the week.
While Covid curbed its New Zealand enthusiasm, Australia charged ahead.
Sick and isolating staff a big concern for already struggling sector.
Receivers expect to retire from role in next six months.
Nano-textile ‘ingredient manufacturer’ (ex-Revolution Fibres) has unicorn-sized ambitions.
US backer refusing to co-operate saying it is ‘outside NZ jurisdiction’.
The deal is understood to be the largest in the country's burgeoning medical cannabis industry.
UPDATE: Seeka to pay 13c/share full-year dividend in February.
Receivers are investigating overstated inventory at core of appointment by Westpac.
Former Finance Minister says organisation 'sits well with my DNA'.
